STI Pharma, LLC has appointed Frank Mullery as president and chief commercial officer. Mr. Mullery has more than 15 years of experience in the pharmaceutical industry, most recently serving as the president, Institutional Business at Mylan, Inc., from 2016 to 2019. In his new role at STI Pharma, he will report to Anup Dam, chairman and manager of STI Pharma.
 
Prior to his role as president of Institutional, Mr. Mullery was chief financial officer of North America for Mylan and held roles of increasing scope and complexity in both the commercial and financial functions for Teva Pharmaceuticals and Viropharma Inc.  
 
“After a comprehensive and thorough search process, we are excited to welcome Frank as our president and chief commercial officer. We believe Frank’s leadership and strategic mindset will build on the solid foundation and leadership team we have in place and maximize the opportunities ahead,” said Anup Dam. Frank has served in a variety of senior leadership roles with some of the largest, most recognized and well-respected companies in the pharmaceutical industry. He is an experienced operational executive with a proven background in driving turnaround and rapid growth, developing new markets, and successfully launching products.  
 
“I am honored to have the opportunity to lead the STI Pharma team. It is a very exciting time to be joining the company,” said Mr. Mullery. “STI is uniquely positioned with a strong base business, a deep and valuable pipeline, and a stellar reputation for quality and innovation.  I am enthusiastic and energized about the opportunities ahead and look forward to working with Anup, the board, our management team and employees to continue strengthening and growing our business, increasing sales and driving operational efficiencies.”